• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

纤维化倾向自身免疫性疾病的一致微生物组特征:IgG4 相关疾病和系统性硬化症。

Congruent microbiome signatures in fibrosis-prone autoimmune diseases: IgG4-related disease and systemic sclerosis.

机构信息

Broad Institute of MIT and Harvard, Cambridge, MA, USA.

Department of Computer Science, Aalto University, 02150, Espoo, Finland.

出版信息

Genome Med. 2021 Feb 28;13(1):35. doi: 10.1186/s13073-021-00853-7.

DOI:10.1186/s13073-021-00853-7
PMID:33648559
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7919092/
Abstract

BACKGROUND

Immunoglobulin G4-related disease (IgG4-RD) and systemic sclerosis (SSc) are rare autoimmune diseases characterized by the presence of CD4+ cytotoxic T cells in the blood as well as inflammation and fibrosis in various organs, but they have no established etiologies. Similar to other autoimmune diseases, the gut microbiome might encode disease-triggering or disease-sustaining factors.

METHODS

The gut microbiomes from IgG4-RD and SSc patients as well as healthy individuals with no recent antibiotic treatment were studied by metagenomic sequencing of stool DNA. De novo assembly-based taxonomic and functional characterization, followed by association and accessory gene set enrichment analysis, were applied to describe microbiome changes associated with both diseases.

RESULTS

Microbiomes of IgG4-RD and SSc patients distinctly separated from those of healthy controls: numerous opportunistic pathogenic Clostridium and typically oral Streptococcus species were significantly overabundant, while Alistipes, Bacteroides, and butyrate-producing species were depleted in the two diseases compared to healthy controls. Accessory gene content analysis in these species revealed an enrichment of Th17-activating Eggerthella lenta strains in IgG4-RD and SSc and a preferential colonization of a homocysteine-producing strain of Clostridium bolteae in SSc. Overabundance of the classical mevalonate pathway, hydroxyproline dehydratase, and fibronectin-binding protein in disease microbiomes reflects potential functional differences in host immune recognition and extracellular matrix utilization associated with fibrosis. Strikingly, the majority of species that were differentially abundant in IgG4-RD and SSc compared to controls showed the same directionality in both diseases. Compared with multiple sclerosis and rheumatoid arthritis, the gut microbiomes of IgG4-RD and SSc showed similar signatures; in contrast, the most differentially abundant taxa were not the facultative anaerobes consistently identified in inflammatory bowel diseases, suggesting the microbial signatures of IgG4-RD and SSc do not result from mucosal inflammation and decreased anaerobism.

CONCLUSIONS

These results provide an initial characterization of gut microbiome ecology in fibrosis-prone IgG4-RD and SSc and reveal microbial functions that offer insights into the pathophysiology of these rare diseases.

摘要

背景

免疫球蛋白 G4 相关疾病(IgG4-RD)和系统性硬化症(SSc)是两种罕见的自身免疫性疾病,其特征为血液中存在 CD4+细胞毒性 T 细胞,以及各种器官的炎症和纤维化,但它们的病因尚未确定。与其他自身免疫性疾病类似,肠道微生物组可能编码疾病触发或维持因素。

方法

通过对粪便 DNA 进行宏基因组测序,研究 IgG4-RD 和 SSc 患者以及近期未接受抗生素治疗的健康个体的肠道微生物组。应用从头组装的分类和功能特征描述、关联和辅助基因集富集分析,来描述与这两种疾病相关的微生物组变化。

结果

IgG4-RD 和 SSc 患者的微生物组与健康对照组明显分离:大量机会性致病梭菌和典型的口腔链球菌明显过度丰富,而在这两种疾病中,与健康对照组相比,Alistipes、Bacteroides 和丁酸盐产生菌被消耗。对这些物种的辅助基因含量分析表明,Th17 激活的 Eggerthella lenta 菌株在 IgG4-RD 和 SSc 中富集,同型半胱氨酸产生的 Clostridium bolteae 菌株优先定植于 SSc。疾病微生物组中经典的甲羟戊酸途径、羟脯氨酸脱水酶和纤维连接蛋白结合蛋白的过度表达反映了宿主免疫识别和细胞外基质利用与纤维化相关的潜在功能差异。引人注目的是,与对照组相比,在 IgG4-RD 和 SSc 中差异丰度较高的大多数物种在这两种疾病中表现出相同的方向性。与多发性硬化症和类风湿关节炎相比,IgG4-RD 和 SSc 的肠道微生物组具有相似的特征;相比之下,差异最大的分类群并不是在炎症性肠病中始终存在的兼性厌氧菌,这表明 IgG4-RD 和 SSc 的微生物特征并非源于黏膜炎症和厌氧菌减少。

结论

这些结果初步描述了易纤维化的 IgG4-RD 和 SSc 中肠道微生物组生态,并揭示了微生物功能,为这些罕见疾病的病理生理学提供了新的见解。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4ef/7919092/e3abbec1ebb3/13073_2021_853_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4ef/7919092/f8f624b18b11/13073_2021_853_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4ef/7919092/f4e2efc997e0/13073_2021_853_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4ef/7919092/322f2225e5a5/13073_2021_853_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4ef/7919092/e3abbec1ebb3/13073_2021_853_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4ef/7919092/f8f624b18b11/13073_2021_853_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4ef/7919092/f4e2efc997e0/13073_2021_853_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4ef/7919092/322f2225e5a5/13073_2021_853_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c4ef/7919092/e3abbec1ebb3/13073_2021_853_Fig4_HTML.jpg

相似文献

1
Congruent microbiome signatures in fibrosis-prone autoimmune diseases: IgG4-related disease and systemic sclerosis.纤维化倾向自身免疫性疾病的一致微生物组特征:IgG4 相关疾病和系统性硬化症。
Genome Med. 2021 Feb 28;13(1):35. doi: 10.1186/s13073-021-00853-7.
2
[Advances in gut microbiomes and immunology of IgG4-related hepatobiliary and pancreatic diseases].[IgG4相关性肝胆胰疾病的肠道微生物群与免疫学进展]
Zhonghua Gan Zang Bing Za Zhi. 2022 Apr 20;30(4):452-456. doi: 10.3760/cma.j.cn501113-20210907-00458.
3
Intestinal microbiome in scleroderma: recent progress.硬皮病的肠道微生物组:最新进展。
Curr Opin Rheumatol. 2017 Nov;29(6):553-560. doi: 10.1097/BOR.0000000000000429.
4
The Microbiome in Systemic Sclerosis: Pathophysiology and Therapeutic Potential.系统性硬化症中的微生物组:发病机制与治疗潜力。
Int J Mol Sci. 2022 Dec 18;23(24):16154. doi: 10.3390/ijms232416154.
5
Overlapping Case of Advanced Systemic Sclerosis and IgG4-Related Disease after Autologous Hematopoietic Stem Cell Transplantation.自体造血干细胞移植后重叠发生的系统性硬化症和 IgG4 相关疾病。
Medicina (Kaunas). 2024 Mar 18;60(3):496. doi: 10.3390/medicina60030496.
6
Gut microbiome profiling in systemic sclerosis: a metagenomic approach.系统性硬化症的肠道微生物组分析:一种宏基因组学方法。
Clin Exp Rheumatol. 2023 Aug;41(8):1578-1588. doi: 10.55563/clinexprheumatol/jof7nx. Epub 2023 Feb 14.
7
Intestinal Dysbiosis and Autoimmune Pancreatitis.肠道菌群失调与自身免疫性胰腺炎。
Front Immunol. 2021 Mar 23;12:621532. doi: 10.3389/fimmu.2021.621532. eCollection 2021.
8
Differential CpG DNA methylation of peripheral B cells, CD4 T cells, and salivary gland tissues in IgG4-related disease.IgG4 相关疾病中外周 B 细胞、CD4 T 细胞和唾液腺组织的差异 CpG DNA 甲基化。
Arthritis Res Ther. 2023 Jan 7;25(1):4. doi: 10.1186/s13075-022-02978-5.
9
The microbiome and systemic sclerosis: A review of current evidence.微生物组与系统性硬化症:当前证据综述。
Best Pract Res Clin Rheumatol. 2021 Sep;35(3):101687. doi: 10.1016/j.berh.2021.101687. Epub 2021 Apr 10.
10
Gut microbiota profile in systemic sclerosis patients with and without clinical evidence of gastrointestinal involvement.系统性硬化症患者有和无胃肠道受累临床表现的肠道微生物群特征。
Sci Rep. 2017 Nov 1;7(1):14874. doi: 10.1038/s41598-017-14889-6.

引用本文的文献

1
mbSparse: an autoencoder-based imputation method to address sparsity in microbiome data.mbSparse:一种基于自动编码器的插补方法,用于解决微生物组数据中的稀疏性问题。
Gut Microbes. 2025 Dec;17(1):2552347. doi: 10.1080/19490976.2025.2552347. Epub 2025 Sep 1.
2
Causal association between gut microbiota and neonatal digestive system diseases: A Mendelian randomization study.肠道微生物群与新生儿消化系统疾病之间的因果关联:一项孟德尔随机化研究。
Medicine (Baltimore). 2025 Aug 15;104(33):e44009. doi: 10.1097/MD.0000000000044009.
3
down regulated flavone and flavonol biosynthesis promoted Kawasaki disease.

本文引用的文献

1
Cytotoxic CD4+ T lymphocytes may induce endothelial cell apoptosis in systemic sclerosis.细胞毒性 CD4+T 淋巴细胞可能在系统性硬皮病中诱导内皮细胞凋亡。
J Clin Invest. 2020 May 1;130(5):2451-2464. doi: 10.1172/JCI131700.
2
T and B lymphocytes in fibrosis and systemic sclerosis.纤维化和系统性硬化症中的 T 和 B 淋巴细胞。
Curr Opin Rheumatol. 2019 Nov;31(6):576-581. doi: 10.1097/BOR.0000000000000644.
3
Microbial genes and pathways in inflammatory bowel disease.炎症性肠病中的微生物基因和途径。
黄酮和黄酮醇生物合成下调促进了川崎病。
Virulence. 2025 Dec;16(1):2512401. doi: 10.1080/21505594.2025.2512401. Epub 2025 May 31.
4
Unraveling the interplay between mesenchymal stem cells, gut microbiota, and systemic sclerosis: therapeutic implications.解析间充质干细胞、肠道微生物群与系统性硬化症之间的相互作用:治疗意义
Microbiol Spectr. 2025 Jun 3;13(6):e0157624. doi: 10.1128/spectrum.01576-24. Epub 2025 Apr 24.
5
RAPO Attenuates Dermal and Pulmonary Fibrosis in a Mouse Model of Systemic Sclerosis through Macrophage Modulation and Growth of Short-Chain Fatty Acid Producers.RAPO通过巨噬细胞调节和短链脂肪酸产生菌的生长减轻系统性硬化症小鼠模型的皮肤和肺纤维化。
Immune Netw. 2024 Dec 17;24(6):e41. doi: 10.4110/in.2024.24.e41. eCollection 2024 Dec.
6
Discriminative features of immunoglobulin G4-related disease (IgG4-RD) and associated autoimmune rheumatic diseases (ARDs) in a nationwide observational cohort: study from the Egyptian College of Rheumatology.全国性观察队列中免疫球蛋白G4相关疾病(IgG4-RD)及相关自身免疫性风湿性疾病(ARDs)的鉴别特征:来自埃及风湿病学会的研究
Clin Rheumatol. 2025 Feb;44(2):747-756. doi: 10.1007/s10067-024-07274-y. Epub 2025 Jan 3.
7
Gut microbiome and metabolomics in systemic sclerosis: feature, link and mechanisms.肠道微生物组和代谢组学在系统性硬化症中的特征、关联和机制。
Front Immunol. 2024 Nov 4;15:1475528. doi: 10.3389/fimmu.2024.1475528. eCollection 2024.
8
Omics in IgG4-related disease.IgG4相关疾病中的组学
Chin Med J (Engl). 2024 Oct 25. doi: 10.1097/CM9.0000000000003320.
9
The increased tendency for anemia in traditional Chinese medicine deficient body constitution is associated with the gut microbiome.中医虚证体质人群贫血倾向增加与肠道微生物群有关。
Front Nutr. 2024 Sep 18;11:1359644. doi: 10.3389/fnut.2024.1359644. eCollection 2024.
10
Serum markers of microbial translocation and intestinal damage in assessment of gastrointestinal tract involvement in systemic sclerosis.血清微生物易位和肠道损伤标志物在系统性硬化症胃肠道受累评估中的作用。
Clin Exp Med. 2024 Sep 19;24(1):225. doi: 10.1007/s10238-024-01466-1.
Nat Rev Microbiol. 2019 Aug;17(8):497-511. doi: 10.1038/s41579-019-0213-6.
4
Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases.炎症性肠病中的肠道微生物生态系统的多组学研究。
Nature. 2019 May;569(7758):655-662. doi: 10.1038/s41586-019-1237-9. Epub 2019 May 29.
5
Autoantibodies are present before the clinical diagnosis of systemic sclerosis.自身抗体在系统性硬化症的临床诊断之前就已经存在。
PLoS One. 2019 Mar 26;14(3):e0214202. doi: 10.1371/journal.pone.0214202. eCollection 2019.
6
Can oral bacteria affect the microbiome of the gut?口腔细菌会影响肠道微生物群吗?
J Oral Microbiol. 2019 Mar 18;11(1):1586422. doi: 10.1080/20002297.2019.1586422. eCollection 2019.
7
Mining the microbiota for microbial and metabolite-based immunotherapies.从微生物组中挖掘基于微生物和代谢物的免疫疗法。
Nat Rev Immunol. 2019 May;19(5):305-323. doi: 10.1038/s41577-019-0144-5.
8
Microbiota-nourishing Immunity and Its Relevance for Ulcerative Colitis.微生物群营养免疫及其与溃疡性结肠炎的相关性。
Inflamm Bowel Dis. 2019 Apr 11;25(5):811-815. doi: 10.1093/ibd/izz004.
9
A defined commensal consortium elicits CD8 T cells and anti-cancer immunity.特定共生菌群可诱导 CD8+T 细胞及抗肿瘤免疫。
Nature. 2019 Jan;565(7741):600-605. doi: 10.1038/s41586-019-0878-z. Epub 2019 Jan 23.
10
Microbiotas from Humans with Inflammatory Bowel Disease Alter the Balance of Gut Th17 and RORγt Regulatory T Cells and Exacerbate Colitis in Mice.炎症性肠病患者的微生物群改变了肠道 Th17 和 RORγt 调节性 T 细胞的平衡,并在小鼠中加重结肠炎。
Immunity. 2019 Jan 15;50(1):212-224.e4. doi: 10.1016/j.immuni.2018.12.015.